AltMountain

RPS BioPharma Holdings, LP

Offshore
Status: no Form D since Apr 2017. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

RPS BioPharma Holdings, LP is a private investment fund based in George Town, Cayman Islands. According to its most recent Form D, filed Apr 10, 2017, it has sold $149,581,598 of interests to 21 investors since its first sale in Mar 2017. The minimum investment it accepts from an outside investor is $100,000. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Pharma Management (Cayman) Ltd; Rory Riggs; Pablo Legorreta.

Total raised
$149,581,598Cumulative sales reported on Form D
Investors
21
First sale
Mar 27, 2017
Minimum investment
$100,000
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Pharma Management (Cayman) Ltd; Rory Riggs; Pablo Legorreta
Latest Form D
Apr 10, 2017

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌‌​​​​​​​​​‌⁠

Questions about RPS BioPharma Holdings, LP

What is the minimum investment for RPS BioPharma Holdings, LP?

According to its latest Form D, filed Apr 10, 2017, the minimum investment RPS BioPharma Holdings, LP accepts from an outside investor is $100,000.

Who can invest in RPS BioPharma Holdings, LP?

RPS BioPharma Holdings, LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has RPS BioPharma Holdings, LP raised?

RPS BioPharma Holdings, LP reports $149,581,598 sold from 21 investors on its Form D filed Apr 10, 2017. This is cumulative sales since the offering began, not current assets or performance.

Where is RPS BioPharma Holdings, LP based?

RPS BioPharma Holdings, LP is based in George Town, Cayman Islands.

When did RPS BioPharma Holdings, LP launch?

RPS BioPharma Holdings, LP reports its first sale in Mar 2017.

Size compared with every private investment fund

Raised more than 75% of the 576 private investment funds based in Cayman Islands, and more than 76% of all 10,363 that report sales.

Other programs from Pharma Management (Cayman) Ltd.

All 5 funds from this sponsor

More private investment funds in George Town

Similar-size private investment funds in Cayman Islands

All private investment funds in Cayman Islands